Latest From Biotech Now

Synthetic Biology Applications for Algae and Renewable Chemicals Featured at 2013 Pac Rim Summit

Pac_Rim115x75

The Biotechnology Industry Organization’s (BIO)’s 2013 Pacific Rim Summit on Biotechnology and Bioenergy will be showcasing several distinctive presentations on recent innovations in using synthetic biology for renewable chemicals and algae biofuels.  This year’s summit will be co-organized by BIOCOM and held in San Diego, California from December 8-11, 2013 at the Westin Gaslamp Quarter. In a recent press release, BIO announced that the Pacific Rim Summit will offer a complete track of breakout sessions on the Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

JOBS Act Deconstructed: Testing-the-Waters

87881842

More than 40 biotech companies have gone public using provisions made available to emerging growth companies through the JOBS Act. BIOtechNOW’s JOBS Act Deconstructed series will explore why it has had such an impact on biotech offerings and how emerging companies can leverage the new law to their best advantage. The JOBS Act enables companies to promote themselves to potential investors in advance of their IPO. Prior to the JOBS Act, companies conducting a public offering Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

GAIN Act: A Great First Step

clinical-trials

With over 2 million infections – and 23,000 deaths – caused by antibiotic resistant bacteria each year in the US, everyone agrees there is an urgent need to find new, effective antibiotic therapies. One measure designed to spur such development is the Generating Antibiotics Incentives Now (GAIN) Act, signed into law last year. Given the growing threat posed by resistant bacteria, we decided to hold a workshop with leading experts about what effect the GAIN Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , ,

UK Bioscience Forum: Confronting Common Challenges

Jim_London115x76

This week, BIO’s President and CEO Jim Greenwood delivered a plenary address to attendees at the UK Bioscience Forum in London, England. Below are excerpts from his speech: We can work together to build the right framework to support innovation. From the way we fund research, to how we protect innovations, to how we attract investment and streamline regulatory approval. The UK has the right innovation ecosystem in place to grow as a global biotech Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

Crowdfunding in Health Care and Biotechnology

JobsAct_photo_115x76

Smaller private companies are constantly in search of capital, but many find it difficult to navigate the step between a “friends and family” round or one with angels and an initial venture round. Crowdfunding has been used in a limited number of examples for life sciences companies, but where is this pathway heading? How should a company look at opportunities for crowdfunding? During the 12th annual BIO Investor Forum, a CEO moderator, Nicholas Franano of Novita Read More >

Business and Investments  |  1 Comment  |  Email This Post
Tags: , , , , , ,